(Q33393705)

26 July 2017

1 reference

title

The etiology of paraneoplastic autoimmunity (English)

1 reference

26 July 2017

Emanual Maverakis

1

0 references

author name string

Heidi Goodarzi

2

1 reference

26 July 2017

Lisa N Wehrli

3

1 reference

26 July 2017

Yoko Ono

4

1 reference

26 July 2017

Miki Shirakawa Garcia

5

1 reference

26 July 2017

publication date

1 April 2012

1 reference

Clinical Reviews in Allergy & Immunology

26 July 2017

published in

1 reference

26 July 2017

volume

42

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

135-144

1 reference

Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Castleman's tumours and production of autoantibody in paraneoplastic pemphigus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Cutaneous manifestations of internal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Sweet's syndrome with hematologic disorders: a review and reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Mucocutaneous paraneoplastic syndromes in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Pyoderma gangrenosum and interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumour necrosis factor-alpha stimulate its secretion in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Quantitative analysis of the T cell repertoire selected by a single peptide-major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Mhc-guided processing: binding of large antigen fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Presentation of a determinant by MHC class II can be prevented through competitive capture by a flanking determinant on a multideterminant peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

How some T cells escape tolerance induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Clearing of Pyoderma gangrenosum by intralesional cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Malignant thymoma: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic pemphigus in association with Castleman's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Autoimmune complications of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

The ITP syndrome: pathogenic and clinical diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic pemphigus: an association with fludarabine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

IRF4 addiction in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Autoimmunity to ion-channels and other proteins in paraneoplastic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

The dual association between lymphoma and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Autoimmunity to gephyrin in Stiff-Man syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8248-5

Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum

21 January 2018

1 reference

12 December 2020

Disease-specific complications of chronic lymphocytic leukemia

1 reference

12 December 2020

Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?

1 reference

12 December 2020

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Pyoderma gangrenosum. A patient successfully treated with intralesional injections of steroid

1 reference

12 December 2020

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies

1 reference

12 December 2020

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

1 reference

12 December 2020

Follicular dendritic cell sarcoma with immature T-cell proliferation

1 reference

12 December 2020

T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking

1 reference

12 December 2020

Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis

1 reference

12 December 2020

CD30+ anaplastic large cell lymphoma complicated by pyoderma gangrenosum with increased levels of serum cytokines

1 reference

12 December 2020

TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL)

1 reference

12 December 2020

Pyoderma gangrenosum: successful treatment with intralesional steroids

1 reference

12 December 2020

Pyoderma gangrenosum; a clinical study of nineteen cases

1 reference

12 December 2020

Disorders of the thymus. A review

1 reference

12 December 2020

Histopathologic and immunopathologic study of pyoderma gangrenosum

1 reference

12 December 2020

Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone

1 reference

12 December 2020

Paraneoplastic pemphigus associated with Castleman's disease and asymptomatic bronchiolitis obliterans

1 reference

12 December 2020

Pyoderma gangrenosum as a cause of splenomegaly and association with a T-cell clone

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts

1 reference

12 December 2020

Paraneoplastic pyoderma gangrenosum

1 reference

12 December 2020

Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus

1 reference

12 December 2020

Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.

1 reference

12 December 2020

Paraneoplastic pemphigus in children and adolescents

1 reference

12 December 2020

10.1007/S12016-010-8248-5

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1022870039

0 references

1 reference